Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization

<p>Adoptive T cell therapy, using T cell receptor-engineered T (TCR-T) cells and chimeric antigen receptor T (CAR-T) cells, is a potent immunotherapy option. Bladder cancer is a prevalent urological malignancy, particularly in cases of muscle invasion and metastasis, for which systemic therapy...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Kanta Hori (20198286) (author)
مؤلفون آخرون:	Shuhei Yamada (2501758) (author), Kenji Murata (500161) (author), Haruka Miyata (3947141) (author), Yuka Mizue (363693) (author), Aiko Murai (683051) (author), Tomoyuki Minowa (20198289) (author), Kenta Sasaki (5945867) (author), Naoki Shijubou (14831091) (author), Terufumi Kubo (482426) (author), Rena Morita (418953) (author), Serina Tokita (11869652) (author), Takayuki Kanaseki (482424) (author), Tomohide Tsukahara (482423) (author), Takashige Abe (7302572) (author), Nobuo Shinohara (667646) (author), Yoshihiko Hirohashi (93294) (author), Toshihiko Torigoe (93291) (author)
منشور في:	2024
الموضوعات:	Cell Biology Immunology Cancer Hematology Infectious Diseases Space Science Urothelial carcinoma CLSPN cisplatin resistance TCR-T immunotherapy
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Establishment of potent TCR-T cells specific for cisplatin-resistance related tumor-associated antigen, CLSPN using codon-optimization

مواد مشابهة